Purpose-Because of high correlations between dairy intake and total dietary calcium, previously reported associations between lower calcium intake and increased kidney stone risk represent de facto associations between milk products and risk. We sought to examine associations between dietary calcium from non-dairy and dairy sources and symptomatic nephrolithiasis.
INTRODUCTION
Lower dietary calcium is an established risk factor for calcium kidney stone formation. In observational studies, we and others previously reported prospective independent associations between lower dietary calcium and increased risk of incident kidney stones. [1] [2] [3] [4] In a randomized trial of 120 men with calcium oxalate stone disease and idiopathic hypercalciuria, Borghi compared the effects of a low calcium (400 mg/d) diet to a higher calcium diet (1200 mg/d) also restricted in sodium (1200 mg/d) and animal protein (52 g/ d). 5 Study participants on the higher calcium diet had a 51% lower risk of recurrent nephrolithiasis than their low-calcium counterparts. The mechanism whereby higher calcium intake may decrease stone risk is unclear; it is possible that more calcium in the intestinal lumen results in lower intestinal absorption (and thus lower urinary excretion) of oxalate. 6, 7 Despite these data, the relations between dietary calcium and kidney stone formation require elucidation. Because of the large contribution of milk products to non-supplemental calcium intake in Western populations, large-scale observational studies to date reporting associations between dietary calcium and stone risk have, to a large extent, delineated associations between dairy intake and risk. Furthermore, in contrast to dietary calcium, higher supplemental calcium intake has been associated with increased, rather than decreased, risk of kidney stone formation. 1, 8 Taken together, these points suggest the important possibility that milk products may contain an unknown factor that inhibits calcium stone formation. To date, no study has examined the association between non-dairy dietary calcium and kidney stone risk.
To examine the independent associations between non-dairy dietary calcium, dairy calcium, and risk of incident symptomatic kidney stones, we conducted prospective analyses in three large cohorts: the Health Professionals Follow-up Study (HPFS) and the Nurses' Health Studies I and II (NHS I and II).
MATERIALS and METHODS

Study populations
In 1986, 51,529 male dentists, optometrists, osteopaths, pharmacists, podiatrists, and veterinarians between the ages of 40 and 75 years enrolled in HPFS by completing and returning an initial questionnaire that provided detailed information on diet, medical history, and medications. This cohort, like NHS I and NHS II, is followed by biennial mailed questionnaires, which include inquiries about newly diagnosed diseases such as kidney stones. We limited the analysis to men who completed at least one dietary questionnaire and excluded participants with a history of kidney stones before 1986. We excluded men ≥ 60 years old because we previously reported inverse associations between calcium intake and stone risk only in HPFS participants < 60. 9 A total of 30,762 men remained in the study group.
In 1976, 121,700 female registered nurses between the ages of 30 and 55 years enrolled in NHS I. Since we first asked NHS I participants about their lifetime history of kidney stones in 1992, the current analysis was limited to women who answered questionnaires in 1992 or later. For this study we started follow-up in 1986. After excluding women with kidney stones before 1986, our study population included 94,164 NHS I participants.
In 1989, 116,430 female registered nurses between the age of 25 and 42 years enrolled in NHS II. Dietary information was first collected from this cohort in 1991. We limited the analysis to women who completed at least one dietary questionnaire and excluded participants with a history of kidney stones before 1991. A total of 101,701 NHS II participants remained in the study group.
Assessment of diet
The baseline semiquantitative food-frequency questionnaires asked about the annual average use of more than 130 individual foods and 22 beverages. Subsequently, a version of this food-frequency questionnaire (FFQ) has been mailed to study participants every 4 years. Intakes of dietary factors were computed from the reported frequency of consumption of each specified unit of food and, with the exception of oxalate, from United States Department of Agriculture data on the content of the relevant nutrient in specified portions. The oxalate content of the majority of foods on the FFQ, as well as frequently consumed write-in foods, was measured by capillary electrophoresis in the laboratory of Dr Ross Holmes. This assay has been described in detail elsewhere. 10, 11 Nutrient values were adjusted for total caloric intake to determine the nutrient composition of the diet independent of the total amount of food eaten. Adjustment was performed using a regression model, with total caloric intake as the independent variable and absolute nutrient intake as the dependent variable. 12, 13 The intake of mineral and vitamin supplements (such as calcium and vitamin D) in multivitamins or isolated form was determined by the brand, type, and frequency of reported use. The reproducibility and validity of the FFQs in the HPFS and NHS I have been documented. 14, 15 
Assessment of non-dietary covariates
For each cohort, information on age, weight and height was obtained on the baseline questionnaire, and age and weight were updated every two years. Body mass index (BMI) was calculated as the weight in kilograms divided by the square of height in meters. Information on thiazide diuretics was updated every two years in HPFS and NHS II. In NHS I, thiazide use was determined in 1980, 1982, and then every six years until 1994, when biennial updates started.
Assessment of incident kidney stones
The primary outcome was an incident kidney stone accompanied by pain or hematuria. The participants reported on the interval diagnosis of kidney stones every two years. Any study participant who reported a new kidney stone on the biennial questionnaire was sent an additional questionnaire to determine the date of occurrence and the symptoms from the stone. In HPFS, we obtained medical records from 582 men who reported a kidney stone and the diagnosis was confirmed in 95%. There were 148 records that contained a stone composition report and 127 men (86%) had a stone that contained ≥ 50% calcium oxalate. In NHS I, we obtained medical records from 194 women who reported a kidney stone and 96% of the records confirmed the diagnosis. There were 78 records that contained a stone composition report and 60 women (77%) had a stone that contained ≥ 50% calcium oxalate. In NHS II, we obtained medical records from 858 women who reported a kidney stone and 98% of the records confirmed the diagnosis. There were 243 records that contained a stone composition report and 191 women (79%) had a stone that contained ≥ 50% calcium oxalate.
Statistical analysis
The study design was prospective; information on diet was collected before the diagnosis of the kidney stone. The relative risk was used as the measure of association between dairy and non-dairy dietary calcium and incident kidney stones. Dairy and non-dairy dietary calcium were divided into quintiles, and the lowest quintiles served as the referent groups. The Mantel extension test was used to evaluate linear trends across categories of intake.
Dietary exposures were updated every four years. We allocated person-time of follow-up according to exposure status at the start of each follow-up period. If complete information on diet was missing at the start of a time period, the participant was excluded from that time period. For HPFS, person-time was counted from the date of the return of the 1986 questionnaire to the date of a kidney stone or death or to January 31, 2006, whichever came first. For NHS I, person-time was counted from the date of the return of the 1986 questionnaire to the date of a kidney stone or death or to May 31, 2006. For NHS II, persontime was counted from the date of the return of the 1991 questionnaire to the date of a kidney stone or death or to May 31, 2007.
We adjusted our analyses for potentially confounding variables using Cox proportional hazards regression. The confounding variables considered were age (continuous), BMI (six categories), history of diabetes, history of hypertension, use of thiazide diuretics (yes or no), family history of kidney stones (yes or no; HPFS and NHS II), fluid intake (in quintiles), alcohol intake (seven categories), calcium supplement use (0 mg/d, 1 to 100 mg/d, 101 to 500 mg/d, and ≥ 500 mg/d), and intakes of animal protein, potassium, sodium, vitamin C, sodium, oxalate, magnesium, and caffeine (all in quintiles). We calculated 95% confidence intervals for all relative risks. All P values are two tailed.
All data were analyzed by using SAS software, version 9.2 (SAS Institute Inc., Cary, North Carolina). The research protocol for this study was reviewed and approved by the institutional review board of Brigham and Women's Hospital.
RESULTS
Over a combined 56 years of follow-up, we documented 5,270 new symptomatic kidney stones in the three cohorts. In HPFS (men), NHS I (older women), and NHS II (younger women), there were 1,133, 1,806, and 2,331 incident kidney stones, respectively.
At baseline, study participants with higher non-dairy dietary calcium were older, were more likely to have a history of diabetes, were more likely to use thiazide diuretics (NHS I and NHS II only), and consumed more supplemental and less dairy calcium (Table 1) . NHS I participants with higher non-dairy dietary calcium had higher BMI and were more likely to have a history of hypertension. At baseline, the fraction of dietary calcium from non-dairy sources (calculated as mean non-dairy dietary calcium/mean total dietary calcium) was 41% for HPFS, 46% for NHS I, and 38% for NHS II. However, the Spearman correlation coefficients between energy-adjusted dairy calcium and total dietary calcium were 0.95 in HPFS, 0.97 in NHS I, and 0.96 in NHS II. In contrast, the correlation coefficients between energy-adjusted non-dairy dietary calcium and total dietary calcium were 0.23 in HPFS, 0.20 in NHS I, and 0.13 in NHS II.
Higher dietary calcium from either non-dairy or dairy sources was associated independently with a lower risk of incident kidney stones in all 3 cohorts (Tables 2 and 3) . The multivariable relative risks in the highest as compared to the lowest quintile of non-dairy dietary calcium were 0.71 (95% confidence interval 0.56 to 0.92; P for trend 0.007) for HPFS, 0.82 (95% confidence interval 0.69 to 0.98; P for trend 0.08) for NHS I, and 0.74 (95% confidence interval 0.63 to 0.87; P for trend 0.002) for NHS II. The multivariable relative risks in the highest as compared to lowest quintile of dairy calcium were 0.77 (95% confidence interval 0.63 to 0.95; P for trend 0.01) for HPFS, 0.83 (95% confidence interval 0.69 to 0.99; P for trend 0.05) for NHS I, and 0.76 (95% confidence interval 0.65 to 0.88; P for trend 0.001) for NHS II.
We also performed analyses stratified by intakes (above and below the median) of total vitamin D, total dietary calcium, and oxalate. The magnitude of the associations between higher non-dairy dietary calcium and dairy calcium and lower kidney stone risk were similar in participants with higher and lower vitamin D intake, higher and lower dietary calcium, and higher and lower oxalate. Additional multivariable adjustment for menopause, as well as analyses restricted to postmenopausal women in NHS I, yielded similar results to the primary analyses.
DISCUSSION
In men and women, higher dietary calcium from either non-dairy or dairy sources is associated with lower risk of incident symptomatic kidney stones. This inverse association is independent of age, body size, dietary factors, intake of fluid and supplemental calcium, thiazide use, and other kidney stone risk factors.
Because of the high correlation between total dietary calcium and dairy intake in Western populations, previous large-scale observational studies of dietary calcium and kidney stone risk represent, de facto, studies of milk products and risk. In Borghi's randomized trial comparing the effects of a higher to a low calcium diet on recurrent calcium oxalate stone formation, calcium restriction was achieved by avoiding dairy (i.e., milk, yogurt, and cheese). 5 The data from our current study allows us to dismiss the important possibility that dairy products were solely responsible for previously observed associations between higher dietary calcium and lower risk of incident kidney stones.
Our results do not provide insight into why dietary calcium may exert different effects on kidney stone risk than supplemental calcium. Supplemental calcium use, in these cohorts and others, is associated with a nominal increase in kidney stone formation. 1, 8 For example, participants in the Women's Health Initiative (WHI) taking 1000 mg of supplemental calcium and 400 IU of vitamin D 3 daily were 17% more likely to have a kidney stone than participants in the placebo group. 8 Because feeding studies suggest that orally administered calcium can reduce intestinal oxalate absorption (and subsequent renal oxalate excretion), 6, 7 it is reasonable to speculate that the effect of supplemental calcium on kidney stone risk depends on whether supplements are taken with or between meals.
Our study has limitations. First, we did not have kidney stone composition reports from all stone formers. Thus, we could not determine whether associations between non-dairy dietary calcium and risk varied by stone type. However, the majority of stone composition reports in each cohort show kidney stones containing ≥ 50% calcium oxalate. Second, as with any observational study, we cannot rule out the possibility of confounding by unknown or unmeasured factors associated with stone risk. Third, data from the validated FFQ can only approximate actual nutrient intake. However, we expect that potential misclassification of dietary intake would be random with respect to subsequent risk of symptomatic nephrolithiasis. Finally, the results of our study may not be generalizable. Only a small fraction of our study population is non-white, and we do not have data on stone formation in men aged less than 40 years.
CONCLUSIONS
Higher dietary calcium, regardless of source, is independently associated with a lower risk of symptomatic kidney stones in 3 large cohorts of free-living individuals. Restriction of dietary calcium should not be recommended as a means of calcium kidney stone prevention. Table 1 Age-standardized characteristics of men < 60 years of age (HPFS), older women (NHS I), and younger women (NHS II) Table 2 Relative risk of incident kidney stones in men < 60 years of age (HPFS) and women (NHS I and NHS II) by quintile of non-dairy dietary calcium. Table 3 Relative risk of incident kidney stones in men < 60 years of age (HPFS) and women (NHS I and NHS II) by quintile of dairy calcium intake. 
